Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.59 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.59 |
| ▸ | PNP | P00491 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CDA | P32320 | 1/20 | 0.35 |
| ▸ | PYGM | P11217 | 3/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.34 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.34 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.34 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xanthine SCHEMBL11134143 | 1.00 | ACHE (0.59) | ACHEGDAPNPMEN1KMT2A | |
| Xanthine SCHEMBL23067651 | 0.84 | ACHE (0.49) | ACHEGDAPNPMEN1KMT2A | |
| Inositol SCHEMBL23881989 | 0.82 | GDA (0.82) | ACHEGDAPNP | |
| Uridine SCHEMBL11232088 | 0.80 | SLC28A1 (0.67) | SLC28A1SLC28A2SLC29A1SLC28A3 | |
| Hypoxanthine SCHEMBL9538156 | 0.80 | ALDH1A1 (0.53) | PNPMEN1KMT2AMAPTCDA | |
| Xanthine SCHEMBL2139667 | 0.77 | GDA (0.79) | ACHEGDAHPGD | |
| Ribose (Furanose) SCHEMBL16620262 | 0.77 | PNP (0.44) | PNPMEN1KMT2AHPGDMAPT | |
| Xanthine SCHEMBL29669592 | 0.77 | GDA (1.00) | ACHEGDAPNPHPGDPAX8 | |
| Xanthine SCHEMBL4965 | 0.77 | GDA (1.00) | ACHEGDAPNPHPGDPAX8 | |
| Xanthine SCHEMBL2352524 | 0.77 | GDA (1.00) | ACHEGDAPNPHPGDPAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114058572-A | Proliferation medium for stem cell 3D simulation culture | 华子昂 | 2022-02-18 | — | — | CN | disclosed |
| CN-114058571-A | Preparation method of proliferation culture medium for stem cell 3D simulation culture | 华子昂 | 2022-02-18 | — | — | CN | disclosed |
| CN-111418710-A | Method for establishing uric acid nephropathy animal model | 北京中医药大学 | 2020-07-17 | — | — | CN | disclosed |
| US-20180292384-A1 | URINE METABOLITE PROFILES IDENTIFY KIDNEY ALLOGRAFT STATUS | CORNELL UNIVERSITY | 2018-10-11 | — | — | US | disclosed |
| EP-3302707-A1 | URINE METABOLITE PROFILES IDENTIFY KIDNEY ALLOGRAFT STATUS | Cornell University (US) | 2018-04-11 | — | — | EP | disclosed |
| WO-2016196329-A1 | URINE METABOLITE PROFILES IDENTIFY KIDNEY ALLOGRAFT STATUS | CORNELL UNIVERSITY (US) | 2016-12-08 | — | — | WO | disclosed |
| EP-0885192-B8 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES (US) | 2012-05-16 | — | — | EP | disclosed |
| EP-0885192-B1 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES (US) | 2012-03-07 | — | — | EP | disclosed |
| EP-2311806-A2 | Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists | The United States of America, Represented by the Secretary, Department of Health and Human Services (US) | 2011-04-20 | — | — | EP | disclosed |
| CN-100410267-C | Soybean isoflavone extract, its preparation process and pharmaceutical compositions containing same | BEIJING BOTAN BIOTECHNOLOGIES (CN) | 2008-08-13 | — | — | CN | disclosed |
| US-20050119462-A1 | Expression vectors and promoters for heterologous gene expression | BIOTECNOL SA (PT) | 2005-06-02 | — | — | US | disclosed |
| EP-1461437-A2 | EXPRESSION VECTORS AND PROMOTERS FOR HETEROLOGOUS GENE EXPRESSION | Biotecnol S.A. (PT) | 2004-09-29 | — | — | EP | disclosed |
| WO-2003056020-A2 | EXPRESSION VECTORS AND PROMOTERS FOR HETEROLOGOUS GENE EXPRESSION | BIOTECNOL SA (PT) | 2003-07-10 | — | — | WO | disclosed |
| EP-0708781-B1 | A 3 ADENOSINE RECEPTOR AGONISTS | USA (US) | 2001-10-04 | — | — | EP | disclosed |
| US-6066642-A | FOR SELECTIVELY BLOCKING THE A3 ADENOSINE RECEPTOR OF A MAMMAL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-23 | — | — | US | disclosed |
| EP-0885192-A1 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1998-12-23 | — | — | EP | disclosed |
| US-5773423-A | XANTHINE RIBOSIDES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-06-30 | — | — | US | disclosed |
| WO-1997027177-A2 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN-4-ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0708781-A1 | A 3 ADENOSINE RECEPTOR AGONISTS | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1996-05-01 | — | — | EP | disclosed |
| WO-1995002604-A1 | A3 ADENOSINE RECEPTOR AGONISTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-01-26 | — | — | WO | disclosed |